Ondine Biomedical Inc.
OBIMF
$0.25
$0.0847.06%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.08M | -6.16M | -4.54M | -4.38M | -4.05M |
| Total Depreciation and Amortization | 100.40K | 101.60K | 112.00K | 108.00K | 100.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 313.50K | 317.30K | 147.80K | 142.50K | 269.70K |
| Change in Net Operating Assets | 764.60K | 774.00K | 601.70K | 580.10K | 676.50K |
| Cash from Operations | -4.90M | -4.96M | -3.68M | -3.54M | -3.00M |
| Capital Expenditure | -33.40K | -33.80K | -8.70K | -8.40K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33.40K | -33.80K | -8.70K | -8.40K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 826.00K |
| Total Debt Repaid | -81.00K | -81.00K | -109.00K | -109.00K | -370.00K |
| Issuance of Common Stock | 10.11M | 10.11M | 2.89M | 2.89M | 8.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -680.50K | -680.50K | -11.00K | -11.00K | -690.50K |
| Cash from Financing | 6.70M | 6.78M | 2.00M | 1.93M | 5.88M |
| Foreign Exchange rate Adjustments | 27.30K | 27.60K | 112.00K | 108.00K | 182.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.79M | 1.81M | -1.57M | -1.52M | 3.06M |